We have developed noninvasive, blood-based, quantitative tests that assess liver health by measuring critical liver cell processes and blood flow to the liver. Our test results support healthcare providers’ clinical decisions to achieve more effective management of patients with advanced liver disease. HepQuant DuO testing delivers a Disease Severity Index (DSI), assessing a patient’s current level of liver impairment and disease state. Results may be used by healthcare providers in conjunction with other clinical tools to aid in the decision to defer invasive procedures or to evaluate a patient’s risk for clinical complications and disease progression.
What We Do
HepQuant products enable healthcare providers to manage patients with liver diseases more effectively as well as to identify people at risk for developing chronic liver disease. We develop non-invasive, quantitative tests that directly measure liver health. Doctors may use results along with full clinical assessment to help risk stratify patients, inform treatment decisions, and monitor efficacy of therapy or disease progression.
The Impact of Liver Disease
The American Liver Foundation estimates 30 to 40% of Americans have some form of liver disease.
That’s more than 100 million people!
About 15 million people
have progressed to advanced fibrosis or cirrhosis, which dramatically increases their risk of liver failure, liver cancer, or death.
Being overweight or obese, having diabetes or high cholesterol are
significant risk factors for liver disease.
Gold Standard Performance
Measure portal shunting to assess portal hypertension.
Easy Sample Collection
One Drink.
Two blood draws.
Noninvasive and Quantitative
Measure cholate in blood to assess liver health.
Robust &
Precise
Help monitor treatment or disease progression.
For Drug Developers
Learn more about how our quantitative test of liver health can be used in clinical trials.
Join Us
We are constantly seeking talented scientists, laboratorians, and business people to catalyze our growth. We provide a place where we do what we love while making a difference in the lives of people with liver disease and the providers who care for them.
HepQuant DuO is a Laboratory Developed Test (LDT). This test was developed and its performance characteristics determined by HepQuant, LLC in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.